Zoenasa Rectal Suspension: Phase I data

A double-blind, mesalamine enema-controlled, U.S. Phase I trial in 6 patients showed that 2 doses of Zoenasa Rectal Suspension did not lead to any serious adverse events. The product has Orphan Drug d...